Not privy to anything - need for 2 trials was publicly announced at the time - and nothing since then to say that requirement has changed.
FDA's strong preference is for 2 Phase 3's in any case - even discounting that, the agreement they reached was for two trials.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
0.025(1.50%) |
Mkt cap ! $2.181B | |||
| Open | High | Low | Value | Volume |
| $1.67 | $1.74 | $1.67 | $4.718M | 2.757M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 18897 | $1.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 53437 | 45 |
View Market Depth
| Last trade - 15.08pm 15/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |